Targets 101: Outlining the Current ADC Target Landscape
Time: 9:05 am
day: Pre-Conference Workshop Day
Details:
This session will allow you to gain detailed knowledge of the current antibody-drug conjugate target landscape, covering both highly saturated clinically validated targets, to more novel explorations. This will provide you with key insights to determine your next ADC target for development.
Join this workshop to get an up-to-date understanding of the current target landscape, from successes and failings of clinically validated targets, to the most interesting advancements in novel targets to influence your pipeline strategy.
The highlights of this workshop include:
- Survey the current clinically validated and novel target landscape for ADCs
- Exploring novel indications and targets outside of the norm
- What will be the next HER2?
